Navigation Links
Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011
Date:10/11/2011

ti-analyte technology platform that delivers fast, accurate and cost-effective bioassay results to markets as diverse as pharmaceutical drug discovery, clinical diagnostics and biomedical research, including the genomics and proteomics research markets. The Company's xMAP technology is sold worldwide and is already in use in leading clinical laboratories as well as major pharmaceutical, diagnostic and biotechnology companies. Further information on Luminex Corporation or xMAP technology can be obtained at www.luminexcorp.com.

Statements made in this release that express Luminex Corporation's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements. The words "believe," "expect," "intend," "estimate," "anticipate," "will," "could," "should" and similar expressions are intended to further identify such forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. It is important to note that the Company's actual results or performance could differ materially from those anticipated or projected in such forward-looking statements. Factors that could cause Luminex's actual results or performance to differ materially include risks and uncertainties relating to, among others, market demand and acceptance of Luminex's products, the Company's dependence on strategic partners for development, commercialization and distribution of products, concentration of the Company's revenue in a limited number of strategic partners, fluctuations in quarterly results due to a lengthy and unpredictable sales cycle and bulk purchases of consumables, Luminex's ability to scale manufacturing operations and manage operating expenses, gross margins and inventory levels, potential shortages of components, competition, the timing of regulatory approvals, the implementation, including any modification, of the Company's strategic operating plans, risks
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Luminex Corporation Hosts Ninth Annual Planet xMAP Europe in Vienna
2. Luminex Corporation to Present at Upcoming Investment Conferences In September
3. Luminex Corporation Reports Second Quarter 2011 Results
4. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
5. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
6. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
7. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
8. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
9. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
10. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
11. Luminex Corporation Reports First Quarter 2011 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
(Date:1/15/2014)... N.J. , Jan. 15, 2014  Celsion Corporation (the "Company") ... has received commitments from institutional investors to purchase an ... stock in an at-the-market registered direct offering, led by ... entered into definitive purchase agreements with these investors pursuant ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
(Date:4/22/2014)... spending, a new RAND study concludes that U.S. policy ... and device makers to develop products that produce more ... their use, a new study suggests the study identifies ... created in the first place. The aim is to ... of health as possible and to ensure that costlier ...
(Date:4/22/2014)... researchers have demonstrated the first size-based form of ... membranes of living cells. This unique physical approach ... critical to whether a cell lives or dies, ... obtained through conventional microscopy. , "We,ve developed membrane-embedded ... to both probe and manipulate membrane assemblies, including ...
(Date:4/22/2014)... been approved since November 2013 for the prevention and ... an early benefit assessment pursuant to the "Act on ... the German Institute for Quality and Efficiency in Health ... an added benefit over the appropriate comparator therapy. ... turoctocog alfa is not proven. As no relevant study ...
(Date:4/22/2014)... chronic inflammatory disorders of the intestine that result in ... in the U.S., and while there are treatments to ... , Now, Cincinnati Cancer Center and University of Cincinnati ... in her lab have done what is believed to ... important function for the Ron receptor, a cell surface ...
(Date:4/22/2014)... of us have gotten stuck in a check-out line ... Mather, assistant professor of physics and an instructor with ... or queues, has been crucial in trying to understand ... of proteins. , The work, submitted during Mather,s first ... the National Science Foundation in the form of a ...
Breaking Medicine News(10 mins):Health News:US medical innovation needs smarter incentives to cut health spending, study finds 2Health News:US medical innovation needs smarter incentives to cut health spending, study finds 3Health News:First size-based chromatography technique for the study of livi 2Health News:First size-based chromatography technique for the study of livi 3Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 2Health News:Turoctocog alfa in patients with hemophilia A: Added benefit not proven 3Health News:Two genes linked to inflammatory bowel disease 2Health News:Queuing theory helps physicist understand protein recycling 2
... 15 Theranostics Health (THX) today,announced that ... research,collaboration agreement with Duke University. This relationship ... core technologies: Laser,Capture Microdissection (LCM) and Reverse ... these technologies provides a powerful,mechanism to accurately ...
... Corporation, a,subsidiary of Orthopedic Development Corporation, announced today ... treat chronic facet-oriented back,pain or to supplement other ... of the two facet joints in each spinal ... treat intractable back pain without,precluding other options, has ...
... Health Solutions, Corp.,("SXC" or the "Company") (NASDAQ: SXCI ... services, announces that Mark Thierer,President and COO and Jeff ... Capital Markets 12th Annual Spring Investor Conference at the ... on Thursday, May 29,2008 at 10:30 am Eastern Time., ...
... important as intervention, specialists say , , THURSDAY, May 15 ... such as pacemakers and defibrillators emphasize that they,re just ... very specific statement of the importance of optimized medical ... University of Alabama at Birmingham,s Division of Cardiovascular Disease, ...
... American College of Physicians (ACP) proposed today a ... and use of information about clinical and cost-effectiveness ... The recommendations are featured in an article, Cost-Effectiveness ... Effectiveness Entity, published online today in Annals of ...
... BIRMINGHAM, Ala., May 15 Diagnostic Health Corporation,(DHC), ... the appointment of Robert E. Gontarek as its ... this role, Gontarek will oversee,the operations of DHC,s ... Gontarek joins DHC with nearly 20 years ...
Cached Medicine News:Health News:Theranostics Health Signs Research Collaboration Agreement 2Health News:TruFUSE(R) Minimally Invasive Facet Fusion Procedure Tops 3,000 Spinal Levels 2Health News:New Guidelines Issued for Implanted Heart Devices 2Health News:Americans must consider cost and effectiveness when comparing and choosing medical interventions 2Health News:Diagnostic Health Corporation Names Robert E. Gontarek as COO 2
... A stethoscope adapter for users of ... and socket" type - must send ... are required. , ,Westone custom ... via our worldwide network of hearing ...
... bronchoscopy: The HF-compatible V series from Pentax, ... bronchoscopes are measured., ,The HF-compatible series ... FB-19TV, FB-18V and FB-15V models along with ... FB-8V, offer much better image quality thanks ...
... from the latest 60 series bronchoscopes., ... range, focussing on providing clinicians with ... Olympus has a impressive range of ... in the respiratory tract to meet ...
Extra-large 3.2mm channel allows excellent suction with EndoTherapy devices in place....
Medicine Products: